Meyka Pro banner
Atai Beckley Inc.

Atai Beckley Inc. (ATAI) Stock Overview

Explore Atai Beckley Inc.’s financial performance, market position, analyst ratings, and future outlook.

ATAINASDAQ
HealthcareBiotechnology
$7.38
$0.04(0.54%)
U.S. Market opens in 6h 42m

Atai Beckley Inc. (ATAI)

Meyka AI Score

Z

Key Financials

Market Cap2.7B
P/E Ratio-2.55
EPS (TTM)$-0.55
ROE-3.53%
Fundamental Analysis

AI Price Forecasts

1 Month$7.83
3 Months$7.22
1 Year Target$5.95

ATAI Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Atai Beckley Inc. (NASDAQ: ATAI) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Atai Beckley Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ATAI on the NASDAQ shows an RSI of 75.88, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $5.95 for the NASDAQ listing.

Key metrics behind Atai Beckley Inc.'s NASDAQ-traded stock include a P/E ratio of -2.55 and a market capitalization of 2.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ATAI on the NASDAQ.

Price Performance (NASDAQ: ATAI)

1-Day Change
-0.54%
5-Day Change
1.93%
1-Month Change
3.36%
3-Month Change
70.44%
6-Month Change
90.21%
Year-to-Date (YTD) Change
80.44%
1-Year Change
68.11%
3-Year Change
352.76%
5-Year Change
-54.05%
All-Time (Max) Change
-62.90%

Contact Information

332 282 0507
250 West 34th Street, New York, NY, 10119

Company Facts

990 Employees
IPO DateJun 18, 2021
CountryUS
Actively Trading

Frequently Asked Questions